logo
Overview
Discover
Watchlists
Portfolios
Heatmap
Sectors
Trendscore
Performers
Alerts
Options
Earnings
Screeners
Scanners
Backtests
Strategies
Comparisons
Charts
Sign in
Sectors
MENS
Jyong Biotech Ltd.
2.23
2 x 1.51
2 x 2.56
bid
ask
-
0.14
5.91%
2 @ 04:04 PM
2.23 +0.00 (0.00%)
Ytd-43.54%
1y-95.93%
2.23
day range
2.40
1.43
52 week range
67.00
Open2.40Prev Close2.37Low2.23High2.40Mkt Cap169.54M
Vol63.23KAvg Vol86.64KEPS-0.06P/EN/AForward P/EN/A
Beta2.29Short Ratio0.56Inst. Own0.14%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning11-1250-d Avg2.15200-d Avg5.801yr Est0.00

MENS News

Jyong Biotech Highlights Multi-Billion Dollar Global BPH Market Opportunity and Reaffirms Strategic Focus on Global Licensing Partnerships
globenewswire.com
Jyong Biotech Highlights Multi-Billion Dollar Global BPH Market Opportunity and Reaffirms Strategic

New Taipei City, Taiwan, July 23, 2026 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the "C

Jyong Biotech Showcases Botanical Drug Portfolio at BIO 2026 International Convention
globenewswire.com
Jyong Biotech Showcases Botanical Drug Portfolio at BIO 2026 International Convention

New Taipei City, Taiwan, July 02, 2026 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “C

12 Health Care Stocks Moving In Monday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session

Gainers Gain Therapeutics (NASDAQ:GANX) stock rose 20.2% to $2.38 during Monday's after-market

Jyong Biotech CEO Outlines FDA Pathway and Global Strategy in PharmaBoardroom Live Interview
globenewswire.com
Jyong Biotech CEO Outlines FDA Pathway and Global Strategy in PharmaBoardroom Live Interview

New Taipei City, Taiwan, May 29, 2026 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “Co

Jyong Biotech Ltd. Files Annual Report on Form 20-F for Fiscal Year 2025
globenewswire.com
Jyong Biotech Ltd. Files Annual Report on Form 20-F for Fiscal Year 2025

New Taipei City, Taiwan, May 15, 2026 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the "Co
benzinga.com
Jyong Biotech Advances Market Access Strategies For Its Plant-Based Drugs Botreso And PCP After Anal

As previously announced, its first core product, Botreso®, has completed four Phase III clinical tri

Jyong Biotech Updates Market Access Strategy for Innovative Botanical Drugs, Establishing Multiple Competitive Advantages for New Drug Portfolio
globenewswire.com
Jyong Biotech Updates Market Access Strategy for Innovative Botanical Drugs, Establishing Multiple C

New Taipei City, Taiwan, April 28, 2026 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “

Jyong Biotech Ltd. (NASDAQ:MENS) Short Interest Down 22.7% in March
defenseworld.net
Jyong Biotech Ltd. (NASDAQ:MENS) Short Interest Down 22.7% in March

Jyong Biotech Ltd. (NASDAQ: MENS - Get Free Report) was the recipient of a large decline in short in

Jyong Biotech Updates the Potential Clinical Benefits and Advantages of Its Plant-Derived Innovative Drug MCS®-2
globenewswire.com
Jyong Biotech Updates the Potential Clinical Benefits and Advantages of Its Plant-Derived Innovative

New Taipei City, Taiwan, March 27, 2026 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “

12 Health Care Stocks Moving In Wednesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session

12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com
Jyong Biotech Completes Phase II Trial For MCS-8, Expands Commercial Presence In Asia

- Comprehensive review of recent milestones highlights statistically significant efficacy in prostat

Jyong Biotech Reports Transformative Period of Clinical Validation and Commercialization Attempt: Phase II Data Focuses on Dual Therapeutic Potential of MCS-8 in Oncology and Metabolic Health, Alongside Strategic Market Entry into Asia
globenewswire.com
Jyong Biotech Reports Transformative Period of Clinical Validation and Commercialization Attempt: Ph

- Comprehensive review of recent milestones highlights statistically significant efficacy in prostat
benzinga.com
Jyong Biotech Announces Updated Statistical Analyses For Key Blood Biochemical Markers From Phase II

Jyong Biotech Ltd. (NASDAQ:MENS) (the "Company" or "Jyong Biotech"), a science-drive

Jyong Biotech Subsidiary Announces Phase II Clinical Data on Cholesterol and LDH Indicators for MCS-8 (PCP), Indicating Potential in Prostate Cancer Prevention and Metabolic Value
globenewswire.com
Jyong Biotech Subsidiary Announces Phase II Clinical Data on Cholesterol and LDH Indicators for MCS-

New Taipei City, Taiwan, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “C

Why Intelligent Bio Solutions Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session
benzinga.com
Why Intelligent Bio Solutions Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving I

Why FuelCell Energy Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
benzinga.com
Why FuelCell Energy Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday

Axsome Therapeutics, Plug Power And Other Big Stocks Moving Higher On Wednesday
benzinga.com
Axsome Therapeutics, Plug Power And Other Big Stocks Moving Higher On Wednesday

12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session

12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session

Sidus Space, Starfighters Space And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
benzinga.com
Sidus Space, Starfighters Space And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session

US Stocks Higher; Nasdaq Surges Over 100 Points
benzinga.com
US Stocks Higher; Nasdaq Surges Over 100 Points
benzinga.com
Jyong Biotech Reaffirms Compliance With Disclosure Obligations Under SEC Regulations, In Discussions

Jyong Biotech Ltd. (Nasdaq: MENS) (the "Company" or "Jyong Biotech") notes the recen

Jyong Biotech Responds to Share Price and Volume Movement
globenewswire.com
Jyong Biotech Responds to Share Price and Volume Movement

New Taipei City, Taiwan, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “C

12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session

12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session

12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session

12 Health Care Stocks Moving In Monday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session

Jyong Biotech Ltd.’s (NASDAQ:MENS) Lock-Up Period Will End on December 15th
defenseworld.net
Jyong Biotech Ltd.’s (NASDAQ:MENS) Lock-Up Period Will End on December 15th

Jyong Biotech's (NASDAQ: MENS - Get Free Report) lock-up period is set to end on Monday, December 15
benzinga.com
Jyong Biotech Enters Into Non-Binding MOU With Vietnam‑Based Pharmaceutical Distribution Company To

Jyong Biotech Ltd. (NASDAQ:MENS) (the "Company" or "Jyong Biotech"), a science-drive

Jyong Biotech Expands Regional Partnerships, Signs MOU with a Vietnam Pharmaceutical Distributor for MCS‑2 Market Entry
globenewswire.com
Jyong Biotech Expands Regional Partnerships, Signs MOU with a Vietnam Pharmaceutical Distributor for

New Taipei City, Taiwan, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “C

Leggett & Platt, New Fortress Energy, Bausch Health Companies And Other Big Stocks Moving Higher On Monday
benzinga.com
Leggett & Platt, New Fortress Energy, Bausch Health Companies And Other Big Stocks Moving Higher On

benzinga.com
Jyong Biotech Signs MoU With South Korean Pharmaceutical Company To Review, Evaluate Licensing, Deve

Jyong Biotech Ltd. (Nasdaq: MENS) (the "Company" or "Jyong Biotech"), a science-driv

Jyong Biotech Ltd. Signs Non‑Binding Letter of Intent with Leading South Korean Pharmaceutical Company to Evaluate In‑Licensing of Plant-Derived MCS Drugs
globenewswire.com
Jyong Biotech Ltd. Signs Non‑Binding Letter of Intent with Leading South Korean Pharmaceutical Compa

New Taipei City, Taiwan, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “C
benzinga.com
Jyong Biotech Completes Statistical Analysis Of Primary Efficacy Endpoints In Ongoing Phase II Clini

Jyong Biotech Ltd. (NASDAQ:MENS) (the "Company" or "Jyong Biotech"), a science-drive

Jyong Biotech Announces Completion of Primary Endpoint Statistical Analysis for Phase II Clinical Trial of MCS-8 With Positive Outcomes
globenewswire.com
Jyong Biotech Announces Completion of Primary Endpoint Statistical Analysis for Phase II Clinical Tr

New Taipei City, Taiwan, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “C

12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session

Caterpillar Posts Upbeat Q3 Results, Joins United Therapeutics, Centene, Fortive And Other Big Stocks Moving Higher On Wednesday
benzinga.com
Caterpillar Posts Upbeat Q3 Results, Joins United Therapeutics, Centene, Fortive And Other Big Stock
benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session

Trump Sparks A 2025 IPO Boom: 5 New Stocks Have Rallied Over 400%
benzinga.com
Trump Sparks A 2025 IPO Boom: 5 New Stocks Have Rallied Over 400%

Trump's second term is fueling an IPO comeback, with 2025 listings up 50% and five stocks alread
benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session

Jyong Biotech Wins Innovation Gold Award in Pharmaceutical Category at 2025 Taipei Biotech Awards
globenewswire.com
Jyong Biotech Wins Innovation Gold Award in Pharmaceutical Category at 2025 Taipei Biotech Awards

New Taipei City, Taiwan, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd.
benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session

Jyong Biotech Chairwoman and CEO Set to Attend as Speaker at 2025 Global Business Forum in Taipei
globenewswire.com
Jyong Biotech Chairwoman and CEO Set to Attend as Speaker at 2025 Global Business Forum in Taipei

New Taipei City, Taiwan, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “

Jyong Biotech Announces Completion of Patient Enrollment of over 700 subjects in Phase II Clinical Trial of MCS‑8 for Prostate Cancer Prevention
globenewswire.com
Jyong Biotech Announces Completion of Patient Enrollment of over 700 subjects in Phase II Clinical T

New Taipei City, Taiwan, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd.
benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session